{"id":"https://openalex.org/W2626325612","doi":"https://doi.org/10.1186/s12885-017-3420-4","title":"A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study","display_name":"A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study","publication_year":2017,"publication_date":"2017-06-19","ids":{"openalex":"https://openalex.org/W2626325612","doi":"https://doi.org/10.1186/s12885-017-3420-4","mag":"2626325612","pmid":"https://pubmed.ncbi.nlm.nih.gov/28629338","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5480259"},"language":"en","primary_location":{"id":"doi:10.1186/s12885-017-3420-4","doi":"https://doi.org/10.1186/s12885-017-3420-4","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12885-017-3420-4","pdf_url":"https://bmccancer.biomedcentral.com/track/pdf/10.1186/s12885-017-3420-4","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmccancer.biomedcentral.com/track/pdf/10.1186/s12885-017-3420-4","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008213572","display_name":"Quentin Jacquinot","orcid":"https://orcid.org/0000-0001-7940-7011","observed_orcids":["https://orcid.org/0000-0001-7940-7011"]},"institutions":[{"id":"https://openalex.org/I4210087978","display_name":"Centre Hospitalier Universitaire de Besan\u00e7on","ror":"https://ror.org/0084te143","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210087978"]},{"id":"https://openalex.org/I90843659","display_name":"Universit\u00e9 de Franche-Comt\u00e9","ror":"https://ror.org/03pcc9z86","country_code":"FR","type":"education","lineage":["https://openalex.org/I4405256580","https://openalex.org/I90843659"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Quentin Jacquinot","raw_affiliation_strings":["EA 3920: Marqueurs pronostiques et facteurs de regulation des pathologies cardiaques et vasculaires, CHU Jean-Minjoz, 25000, Besan\u00e7on, France. quentin.jacquinot@edu.univ-fcomte.fr","Service d'Oncologie M\u00e9dicale, CHU Jean-Minjoz, 25000, Besan\u00e7on, France. quentin.jacquinot@edu.univ-fcomte.fr","UPFR des Sports, Universit\u00e9 de Franche-Comt\u00e9, 31 chemin de l'Epitaphe, 25000, Besan\u00e7on, France. quentin.jacquinot@edu.univ-fcomte.fr","UPFR des Sports, Universit\u00e9 de Franche-Comt\u00e9, 31 chemin de l'Epitaphe, 25000, Besan\u00e7on, France"],"raw_orcid":"https://orcid.org/0000-0001-7940-7011","affiliations":[{"raw_affiliation_string":"EA 3920: Marqueurs pronostiques et facteurs de regulation des pathologies cardiaques et vasculaires, CHU Jean-Minjoz, 25000, Besan\u00e7on, France. quentin.jacquinot@edu.univ-fcomte.fr","institution_ids":["https://openalex.org/I4210087978"]},{"raw_affiliation_string":"Service d'Oncologie M\u00e9dicale, CHU Jean-Minjoz, 25000, Besan\u00e7on, France. quentin.jacquinot@edu.univ-fcomte.fr","institution_ids":["https://openalex.org/I4210087978"]},{"raw_affiliation_string":"UPFR des Sports, Universit\u00e9 de Franche-Comt\u00e9, 31 chemin de l'Epitaphe, 25000, Besan\u00e7on, France. quentin.jacquinot@edu.univ-fcomte.fr","institution_ids":["https://openalex.org/I90843659"]},{"raw_affiliation_string":"UPFR des Sports, Universit\u00e9 de Franche-Comt\u00e9, 31 chemin de l'Epitaphe, 25000, Besan\u00e7on, France","institution_ids":["https://openalex.org/I90843659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070583408","display_name":"Nathalie M\u00e9neveau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087978","display_name":"Centre Hospitalier Universitaire de Besan\u00e7on","ror":"https://ror.org/0084te143","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210087978"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nathalie Meneveau","raw_affiliation_strings":["Service d'Oncologie M\u00e9dicale, CHU Jean-Minjoz, 25000, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service d'Oncologie M\u00e9dicale, CHU Jean-Minjoz, 25000, Besan\u00e7on, France","institution_ids":["https://openalex.org/I4210087978"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011071642","display_name":"Marion Chatot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087978","display_name":"Centre Hospitalier Universitaire de Besan\u00e7on","ror":"https://ror.org/0084te143","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210087978"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marion Chatot","raw_affiliation_strings":["Service de Cardiologie, CHU Jean-Minjoz, 25000, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de Cardiologie, CHU Jean-Minjoz, 25000, Besan\u00e7on, France","institution_ids":["https://openalex.org/I4210087978"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064556770","display_name":"Franck Bonnetain","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210087978","display_name":"Centre Hospitalier Universitaire de Besan\u00e7on","ror":"https://ror.org/0084te143","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210087978"]},{"id":"https://openalex.org/I4210094945","display_name":"Methodology and Quality of Life Unit in Oncology","ror":"https://ror.org/00n1qg914","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210087978","https://openalex.org/I4210094945","https://openalex.org/I4210155509"]},{"id":"https://openalex.org/I4405257954","display_name":"Interactions H\u00f4te-Greffon-Tumeur & Ing\u00e9nierie Cellulaire et G\u00e9nique","ror":"https://ror.org/05w3vvc59","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210128919","https://openalex.org/I4405256580","https://openalex.org/I4405257954"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Franck Bonnetain","raw_affiliation_strings":["INSERM UMR 1098: Unit\u00e9 de m\u00e9thodologie et de qualit\u00e9 de vie en canc\u00e9rologie, CHU Jean-Minjoz, 25000, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM UMR 1098: Unit\u00e9 de m\u00e9thodologie et de qualit\u00e9 de vie en canc\u00e9rologie, CHU Jean-Minjoz, 25000, Besan\u00e7on, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210087978","https://openalex.org/I4210094945","https://openalex.org/I4405257954"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020733605","display_name":"Bruno Degano","orcid":"https://orcid.org/0000-0003-1644-7264","observed_orcids":["https://orcid.org/0000-0003-1644-7264"]},"institutions":[{"id":"https://openalex.org/I4210087978","display_name":"Centre Hospitalier Universitaire de Besan\u00e7on","ror":"https://ror.org/0084te143","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210087978"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Bruno Degano","raw_affiliation_strings":["EA 3920: Marqueurs pronostiques et facteurs de regulation des pathologies cardiaques et vasculaires, CHU Jean-Minjoz, 25000, Besan\u00e7on, France","Physiologie-Explorations Fonctionnelles, CHU Jean-Minjoz, 25000, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EA 3920: Marqueurs pronostiques et facteurs de regulation des pathologies cardiaques et vasculaires, CHU Jean-Minjoz, 25000, Besan\u00e7on, France","institution_ids":["https://openalex.org/I4210087978"]},{"raw_affiliation_string":"Physiologie-Explorations Fonctionnelles, CHU Jean-Minjoz, 25000, Besan\u00e7on, France","institution_ids":["https://openalex.org/I4210087978"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107379312","display_name":"Malika Bouhaddi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087978","display_name":"Centre Hospitalier Universitaire de Besan\u00e7on","ror":"https://ror.org/0084te143","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210087978"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Malika Bouhaddi","raw_affiliation_strings":["EA 3920: Marqueurs pronostiques et facteurs de regulation des pathologies cardiaques et vasculaires, CHU Jean-Minjoz, 25000, Besan\u00e7on, France","Physiologie-Explorations Fonctionnelles, CHU Jean-Minjoz, 25000, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EA 3920: Marqueurs pronostiques et facteurs de regulation des pathologies cardiaques et vasculaires, CHU Jean-Minjoz, 25000, Besan\u00e7on, France","institution_ids":["https://openalex.org/I4210087978"]},{"raw_affiliation_string":"Physiologie-Explorations Fonctionnelles, CHU Jean-Minjoz, 25000, Besan\u00e7on, France","institution_ids":["https://openalex.org/I4210087978"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033552042","display_name":"Gilles Dumoulin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087978","display_name":"Centre Hospitalier Universitaire de Besan\u00e7on","ror":"https://ror.org/0084te143","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210087978"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Gilles Dumoulin","raw_affiliation_strings":["EA 3920: Marqueurs pronostiques et facteurs de regulation des pathologies cardiaques et vasculaires, CHU Jean-Minjoz, 25000, Besan\u00e7on, France","Laboratoire de Biochimie Endocrinienne et M\u00e9tabolique, CHU Jean-Minjoz, 25000, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EA 3920: Marqueurs pronostiques et facteurs de regulation des pathologies cardiaques et vasculaires, CHU Jean-Minjoz, 25000, Besan\u00e7on, France","institution_ids":["https://openalex.org/I4210087978"]},{"raw_affiliation_string":"Laboratoire de Biochimie Endocrinienne et M\u00e9tabolique, CHU Jean-Minjoz, 25000, Besan\u00e7on, France","institution_ids":["https://openalex.org/I4210087978"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110469526","display_name":"D\u00e9wi Vernerey","orcid":"https://orcid.org/0000-0001-6399-926X","observed_orcids":["https://orcid.org/0000-0001-6399-926X"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210087978","display_name":"Centre Hospitalier Universitaire de Besan\u00e7on","ror":"https://ror.org/0084te143","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210087978"]},{"id":"https://openalex.org/I4210094945","display_name":"Methodology and Quality of Life Unit in Oncology","ror":"https://ror.org/00n1qg914","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210087978","https://openalex.org/I4210094945","https://openalex.org/I4210155509"]},{"id":"https://openalex.org/I4405257954","display_name":"Interactions H\u00f4te-Greffon-Tumeur & Ing\u00e9nierie Cellulaire et G\u00e9nique","ror":"https://ror.org/05w3vvc59","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210128919","https://openalex.org/I4405256580","https://openalex.org/I4405257954"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Dewi Vernerey","raw_affiliation_strings":["INSERM UMR 1098: Unit\u00e9 de m\u00e9thodologie et de qualit\u00e9 de vie en canc\u00e9rologie, CHU Jean-Minjoz, 25000, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM UMR 1098: Unit\u00e9 de m\u00e9thodologie et de qualit\u00e9 de vie en canc\u00e9rologie, CHU Jean-Minjoz, 25000, Besan\u00e7on, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210087978","https://openalex.org/I4210094945","https://openalex.org/I4405257954"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044903892","display_name":"Xavier B. Pivot","orcid":"https://orcid.org/0000-0003-3689-5013","observed_orcids":["https://orcid.org/0000-0003-3689-5013"]},"institutions":[{"id":"https://openalex.org/I4210087978","display_name":"Centre Hospitalier Universitaire de Besan\u00e7on","ror":"https://ror.org/0084te143","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210087978"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Xavier Pivot","raw_affiliation_strings":["Service d'Oncologie M\u00e9dicale, CHU Jean-Minjoz, 25000, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service d'Oncologie M\u00e9dicale, CHU Jean-Minjoz, 25000, Besan\u00e7on, France","institution_ids":["https://openalex.org/I4210087978"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108399926","display_name":"Fabienne Mougin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087978","display_name":"Centre Hospitalier Universitaire de Besan\u00e7on","ror":"https://ror.org/0084te143","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210087978"]},{"id":"https://openalex.org/I90843659","display_name":"Universit\u00e9 de Franche-Comt\u00e9","ror":"https://ror.org/03pcc9z86","country_code":"FR","type":"education","lineage":["https://openalex.org/I4405256580","https://openalex.org/I90843659"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fabienne Mougin","raw_affiliation_strings":["EA 3920: Marqueurs pronostiques et facteurs de regulation des pathologies cardiaques et vasculaires, CHU Jean-Minjoz, 25000, Besan\u00e7on, France","UPFR des Sports, Universit\u00e9 de Franche-Comt\u00e9, 31 chemin de l'Epitaphe, 25000, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EA 3920: Marqueurs pronostiques et facteurs de regulation des pathologies cardiaques et vasculaires, CHU Jean-Minjoz, 25000, Besan\u00e7on, France","institution_ids":["https://openalex.org/I4210087978"]},{"raw_affiliation_string":"UPFR des Sports, Universit\u00e9 de Franche-Comt\u00e9, 31 chemin de l'Epitaphe, 25000, Besan\u00e7on, France","institution_ids":["https://openalex.org/I90843659"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5008213572"],"corresponding_institution_ids":["https://openalex.org/I4210087978","https://openalex.org/I90843659"],"apc_list":{"value":3390,"currency":"USD","value_usd":3390},"apc_paid":{"value":2160,"currency":"EUR","value_usd":2329},"fwci":2.5282,"has_fulltext":true,"cited_by_count":34,"citation_normalized_percentile":{"value":0.90364594,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"17","issue":"1","first_page":"425","last_page":"425"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.8184000253677368,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.8184000253677368,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.11590000241994858,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11209","display_name":"Cardiovascular and exercise physiology","score":0.014600000344216824,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9700000286102295},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9440000057220459},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.984000027179718},{"id":"https://openalex.org/keywords/supervised-exercise","display_name":"supervised exercise","score":0.7020000219345093},{"id":"https://openalex.org/keywords/intermittent-exercise","display_name":"intermittent exercise","score":0.5809999704360962},{"id":"https://openalex.org/keywords/left-ventricular-ejection-fraction","display_name":"left ventricular ejection fraction","score":0.9739999771118164},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.8529999852180481},{"id":"https://openalex.org/keywords/cardiorespiratory-fitness","display_name":"cardiorespiratory fitness","score":0.8299999833106995},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.9679999947547913},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.8640000224113464},{"id":"https://openalex.org/keywords/exercise","display_name":"physical activity","score":0.6140000224113464},{"id":"https://openalex.org/keywords/exercise-intervention","display_name":"exercise intervention","score":0.37299999594688416},{"id":"https://openalex.org/keywords/muscle-strength","display_name":"muscle strength","score":0.5099999904632568},{"id":"https://openalex.org/keywords/trial-design","display_name":"trial design","score":0.7929999828338623},{"id":"https://openalex.org/keywords/cardio-oncology","display_name":"cardio-oncology","score":0.5249999761581421}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9308164119720459},{"id":"https://openalex.org/C2778233292","wikidata":"https://www.wikidata.org/wiki/Q2118956","display_name":"Cardiotoxicity","level":3,"score":0.8160111308097839},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7326198816299438},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.6154980063438416},{"id":"https://openalex.org/C78085059","wikidata":"https://www.wikidata.org/wiki/Q641303","display_name":"Ejection fraction","level":3,"score":0.6057462096214294},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5542268753051758},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.5445877909660339},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5257661938667297},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5128381848335266},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4183283746242523},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.41064757108688354},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.37498044967651367},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2284265160560608},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.17289316654205322},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002985","descriptor_name":"Clinical Protocols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005081","descriptor_name":"Exercise Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015444","descriptor_name":"Exercise","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D066126","descriptor_name":"Cardiotoxicity","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D066126","descriptor_name":"Cardiotoxicity","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D066126","descriptor_name":"Cardiotoxicity","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1186/s12885-017-3420-4","doi":"https://doi.org/10.1186/s12885-017-3420-4","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12885-017-3420-4","pdf_url":"https://bmccancer.biomedcentral.com/track/pdf/10.1186/s12885-017-3420-4","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4328617","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC5480259","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5480259","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5480259","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"Text"},{"id":"pmid:28629338","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28629338","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC cancer","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:doaj.org/article:51125522a32e4989bcba30586fbc60c4","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/51125522a32e4989bcba30586fbc60c4","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMC Cancer, Vol 17, Iss 1, Pp 1-11 (2017)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s12885-017-3420-4","doi":"https://doi.org/10.1186/s12885-017-3420-4","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12885-017-3420-4","pdf_url":"https://bmccancer.biomedcentral.com/track/pdf/10.1186/s12885-017-3420-4","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/study-protocol","display_name":"Study Protocol"}],"awards":[{"id":"https://openalex.org/G3641665579","display_name":null,"funder_award_id":"N\u00b08FI11826PYRO","funder_id":"https://openalex.org/F4320322363","funder_display_name":"Ligue Contre le Cancer"}],"funders":[{"id":"https://openalex.org/F4320322363","display_name":"Ligue Contre le Cancer","ror":"https://ror.org/00rkrv905"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2626325612.pdf","grobid_xml":"https://content.openalex.org/works/W2626325612.grobid-xml"},"referenced_works_count":58,"referenced_works":["https://openalex.org/W174733947","https://openalex.org/W1665557198","https://openalex.org/W1833172369","https://openalex.org/W1963821095","https://openalex.org/W1970675431","https://openalex.org/W1971381959","https://openalex.org/W1974136135","https://openalex.org/W1988520146","https://openalex.org/W1996753689","https://openalex.org/W2005570569","https://openalex.org/W2013338689","https://openalex.org/W2017969837","https://openalex.org/W2018773609","https://openalex.org/W2023606650","https://openalex.org/W2024587010","https://openalex.org/W2027369370","https://openalex.org/W2029542561","https://openalex.org/W2029986670","https://openalex.org/W2030387756","https://openalex.org/W2040935952","https://openalex.org/W2045324973","https://openalex.org/W2045827836","https://openalex.org/W2058537058","https://openalex.org/W2066028007","https://openalex.org/W2069618315","https://openalex.org/W2071338518","https://openalex.org/W2076803848","https://openalex.org/W2093015701","https://openalex.org/W2099879261","https://openalex.org/W2100491190","https://openalex.org/W2100748427","https://openalex.org/W2101099004","https://openalex.org/W2101253730","https://openalex.org/W2106787323","https://openalex.org/W2120940824","https://openalex.org/W2121842052","https://openalex.org/W2133026620","https://openalex.org/W2135528979","https://openalex.org/W2141393790","https://openalex.org/W2141595244","https://openalex.org/W2141966658","https://openalex.org/W2146384083","https://openalex.org/W2149568734","https://openalex.org/W2149908785","https://openalex.org/W2151607481","https://openalex.org/W2156420703","https://openalex.org/W2159459001","https://openalex.org/W2160234571","https://openalex.org/W2167571044","https://openalex.org/W2169281409","https://openalex.org/W2170328295","https://openalex.org/W2171129594","https://openalex.org/W2318605753","https://openalex.org/W2405764271","https://openalex.org/W2407883122","https://openalex.org/W2607031541","https://openalex.org/W3005446099","https://openalex.org/W4244598283"],"related_works":["https://openalex.org/W4297002082","https://openalex.org/W3023614791","https://openalex.org/W4366988499","https://openalex.org/W2339738484","https://openalex.org/W4392524927","https://openalex.org/W7127583148","https://openalex.org/W4225966298","https://openalex.org/W2552999094","https://openalex.org/W2981868829","https://openalex.org/W2927791851"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,76],"overexpression":[2],"of":[3,50,60,67,78,86,100,125,149,156,165,167,187,193,206,227,247,264,278,294,311,330],"human":[4],"epidermal":[5],"growth":[6],"factor":[7],"receptor-2":[8],"(HER2)":[9],"in":[10,29,69,95,250,269,334],"breast":[11,74,119,251,274],"cancer":[12,120,252],"is":[13,22,81,240],"a":[14,27,126,154,265],"poor":[15],"prognosis.":[16],"Trastuzumab":[17],"improves":[18],"overall":[19],"survival":[20],"but":[21,302],"associated":[23],"with":[24,71,271,283],"cardiotoxicity,":[25],"especially":[26],"decline":[28],"left":[30],"ventricular":[31],"ejection":[32],"fraction":[33],"(LVEF).":[34],"In":[35],"addition,":[36],"chemotherapy":[37],"and":[38,42,47,94,136,171,175,182,191,217,231,289,300,307],"radiotherapy":[39],"increase":[40,304],"fatigue":[41],"pain,":[43],"decrease":[44,155],"physical":[45,61,194,238,266],"capacity":[46],"health-related":[48,309],"quality":[49,186,310],"life.":[51,312],"To":[52],"date,":[53],"no":[54,254],"study":[55,80,256],"has":[56,257],"evaluated":[57],"the":[58,64,84,98,123,147,157,207,225,244,262,328],"benefits":[59,263,315],"activity":[62,195],"on":[63,91,97,146,176],"side":[65,245],"effects":[66,124,246],"treatment":[68,331],"patients":[70,111,270,326],"HER2":[72,117,272],"positive":[73,118],"cancer.":[75,275],"aim":[77],"this":[79,318],"to":[82,121,204,242,260,325,336],"evaluate":[83],"impact":[85],"3":[87,127,142,173],"months'":[88,128],"exercise":[89,130,229,239,285,319],"intervention":[90,320],"myocardial":[92],"function":[93],"particular":[96],"rate":[99,148],"cardiotoxicity.":[101],"METHODS:":[102],"This":[103,292],"multicenter,":[104],"randomized":[105,255],"clinical":[106],"trial":[107],"will":[108,196],"include":[109],"112":[110],"treated":[112],"by":[113,152,332],"adjuvant":[114,248],"trastuzumab":[115,279,333],"for":[116],"investigate":[122],"supervised":[129,228],"program":[131,230,268,286,295],"(intermittent":[132],"exercise,":[133],"combining":[134,287],"moderate":[135,290],"high":[137,288],"intensities;":[138],"55":[139],"minutes":[140],"duration,":[141],"times":[143],"per":[144],"week),":[145],"cardiotoxicity":[150],"[defined":[151],"either":[153],"LVEF":[158,166],"under":[159],"50%":[160],"or":[161],"an":[162,284],"absolute":[163],"drop":[164],"10%]":[168],"between":[169],"baseline":[170],"at":[172,222,224,232],"months":[174,234],"strength,":[177],"aerobic":[178],"capacity,":[179],"metabolic,":[180],"inflammatory":[181],"hormonal":[183],"parameters.":[184],"Health-related":[185],"life,":[188],"fatigue,":[189],"pain":[190],"level":[192],"also":[197,303],"be":[198,281,297,322],"assessed.":[199],"Participants":[200],"are":[201,220,316],"randomly":[202],"allocated":[203],"one":[205],"two":[208],"groups":[209],"(\"training":[210],"group\"":[211],"vs":[212],"\"standard":[213],"oncological":[214,338],"care\").":[215],"Performance-based":[216],"self-reported":[218],"outcomes":[219],"assessed":[221],"baseline,":[223],"end":[226],"six":[233],"follow-up.":[235],"DISCUSSION:":[236],"Although":[237],"recommended":[241],"reduce":[243],"treatments":[249],"patients,":[253],"been":[258],"conducted":[259],"assess":[261],"training":[267],"overexpressing":[273],"Cardiac":[276],"toxicity":[277],"may":[280,296],"minimized":[282],"intensities.":[291],"type":[293],"safe,":[298],"feasible":[299],"effective":[301],"cardiorespiratory":[305],"fitness":[306],"improve":[308],"If":[313],"these":[314],"confirmed,":[317],"could":[321],"systematically":[323],"proposed":[324],"during":[327],"course":[329],"addition":[335],"standard":[337],"care.":[339],"TRIAL":[340],"REGISTRATION:":[341],"National":[342],"Clinical":[343],"Trials":[344],"Number":[345],"(":[346],"NCT02433067":[347],");":[348],"Registration":[349],"28":[350],"april":[351],"2015.":[352]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-06-23T00:00:00"}